States, cities seek to hold drug companies accountable for public health emergency
HOUSTON – The Lanier Law Firm’s pharmaceutical litigation team is taking a leading role in partnering with state and local governments across the country to hold pharmaceutical companies accountable for a public health emergency caused by the reckless spread of powerful and addictive prescription opioids. Continue reading “Lanier Law Firm Takes Lead in Opioid Epidemic Lawsuits”
HOUSTON – Acclaimed Houston trial lawyer Richard “Rick” Meadow of The Lanier Law Firm has been named to the Plaintiffs’ Executive Committee in the federal multi-district litigation against Johnson & Johnson over ovarian cancer claims involving the company’s talcum powder products.
Continue reading “Rick Meadow of Lanier Law Firm Gets Key Role in Cancer Lawsuits against J&J”
Attorney Mark Lanier: Third MDL bellwether trial sends strong message
DALLAS – A federal jury in Dallas has returned a combined verdict of more than $1 billion on behalf of six people who suffered serious medical complications caused by defective metal-on-metal hip implants made by Johnson & Johnson (NYSE: JNJ) and its subsidiary DePuy/J&J Orthopaedics Inc.
The verdict includes more than $30 million in actual damages for the six plaintiffs and more than $1 billion in punitive damages assessed against Johnson & Johnson and DePuy/J&J.
Lanier Law Firm wins ruling that victims’ cases will be heard in September
DALLAS – A federal judge in Dallas has cleared the way for a September trial in the ongoing multidistrict litigation filed against DePuy/J&J Orthopaedics Inc., a subsidiary of Johnson & Johnson (NYSE: JNJ), by patients who suffered medical problems after receiving the company’s Pinnacle metal-on-metal hip implants.
Continue reading “Texas Federal Court Rules DePuy/J&J Hip Implant Trials in Dallas Will Proceed”
DePuy/J&J Orthopaedics found liable for metal-on-metal implant failures
DALLAS – A federal jury in Dallas has awarded a significant verdict to five people who suffered a variety of debilitating physical problems after receiving metal-on-metal hip implants manufactured by DePuy/J&J Orthopaedics Inc., a subsidiary of New Brunswick, New Jersey-based Johnson & Johnson (NYSE: JNJ).